Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand. Salvadori N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al. Int J Infect Dis 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.

Read + Share

Amedeo Smart

Independent Medical Education

Salvadori N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al. Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand. Int J Infect Dis 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.
PMID: 38561040